News & Updates

Show Multimedia Only
Nivolumab-ipilimumab combo plus surgery improves survival in HCC
Nivolumab-ipilimumab combo plus surgery improves survival in HCC
11 Feb 2026 byStephen Padilla

Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.

Nivolumab-ipilimumab combo plus surgery improves survival in HCC
11 Feb 2026
Harnessing the microbiome for autism: From diagnosis to treatment
Harnessing the microbiome for autism: From diagnosis to treatment
11 Feb 2026 byKanas Chan

Modulation of the gut microbiota may be an effective therapeutic approach for autism spectrum disorder (ASD). A noninvasive test using a panel of multikingdom microbiome and functional markers is available to help diagnose ASD.

Harnessing the microbiome for autism: From diagnosis to treatment
11 Feb 2026
The rising incidence of childhood allergies in Malaysia highlights the urgent need for parental awareness and proactive manag
The rising incidence of childhood allergies in Malaysia highlights the urgent need for parental awareness and proactive management.
11 Feb 2026 bySaras Ramiya, Senior Editor, MPF

An increase in childhood allergies in Malaysia has become a significant health concern, with triggers ranging from dust mites to severe food reactions. This underscores the urgent need for parents to understand, manage, and prevent these conditions.

The rising incidence of childhood allergies in Malaysia highlights the urgent need for parental awareness and proactive management.
11 Feb 2026